...
首页> 外文期刊>Journal of Lipid Research >Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying
【24h】

Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying

机译:肠道DGAT1缺乏症通过抑制乳糜微粒分泌和延迟胃排空减少了餐后甘油三酸酯和视黄酯的偏移

获取原文
获取原文并翻译 | 示例

摘要

Acyl CoA:diacylglycerol acyltransferase (DGAT) 1 catalyzes the final step of triglyceride (TG) synthesis. We show that acute administration of a DGAT1 inhibitor (DGAT1i) by oral gavage or genetic deletion of intestinal Dgat1 (intestine-Dgat1 -/-) markedly reduced postprandial plasma TG and retinyl ester excursions by inhibiting chylomicron secretion in mice. Loss of DGAT1 activity did not affect the efficiency of retinol esterification, but it did reduce TG and retinoid accumulation in the small intestine. In contrast, inhibition of microsomal triglyceride transfer protein (MTP) reduced chylomicron secretion after oral fat/retinol loads, but with accumulation of dietary TG and retinoids in the small intestine. Lack of intestinal accumulation of TG and retinoids in DGAT1i-treated or intestine-Dgat1 -/- mice resulted, in part, from delayed gastric emptying associated with increased plasma levels of glucagon-like peptide (GLP)-1. However, neither bypassing the stomach through duodenal oil injection nor inhibiting the receptor for GLP-1 normalized postprandial TG or retinyl esters excursions in the absence of DGAT1 activity. In summary, intestinal DGAT1 inhibition or deficiency acutely delayed gastric emptying and inhibited chylomicron secretion; however, the latter occurred when gastric emptying was normal or when lipid was administered directly into the small intestine. Long-term hepatic retinoid metabolism was not impacted by DGAT1 inhibition.
机译:酰基CoA:二酰基甘油酰基转移酶(DGAT)1催化甘油三酸酯(TG)合成的最后一步。我们显示,通过口服管饲或肠道Dgat1(肠-Dgat1-/-)的基因缺失对DGAT1抑制剂(DGAT1i)进行急性给药,可通过抑制小鼠乳糜微粒的分泌显着减少餐后血浆TG和视黄酯的偏移。 DGAT1活性的丧失不影响视黄醇酯化的效率,但确实减少了小肠中的TG和类维生素A的积累。相比之下,口服脂肪/视黄醇负荷后抑制微粒体甘油三酸酯转移蛋白(MTP)会减少乳糜微粒的分泌,但在小肠中会积累膳食TG和类维生素A。在DGAT1i治疗或肠道Dgat1-/-小鼠中,TG和类维生素A缺乏肠道蓄积,部分原因是胃排空延迟,血浆胰高血糖素样肽(GLP)-1水平升高。但是,在没有DGAT1活性的情况下,既不通过十二指肠注油绕过胃,也不抑制GLP-1标准化的餐后TG或视黄酯漂移。总之,肠道DGAT1的抑制或缺乏会严重延迟胃排空并抑制乳糜微粒的分泌。然而,后者发生在正常的胃排空或将脂质直接注入小肠时。 DGAT1抑制不影响长期肝类维生素A代谢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号